113 related articles for article (PubMed ID: 27626244)
1. [Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology].
Valeev VV; Trashkov AP; Kovalenko AL; Vasil'ev AG
Angiol Sosud Khir; 2016; 22(3):9-15. PubMed ID: 27626244
[TBL] [Abstract][Full Text] [Related]
2. L-arginine in cardiovascular disease: dream or reality?
Tousoulis D; Antoniades C; Tentolouris C; Goumas G; Stefanadis C; Toutouzas P
Vasc Med; 2002 Aug; 7(3):203-11. PubMed ID: 12553744
[TBL] [Abstract][Full Text] [Related]
3. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
Böger RH; Ron ES
Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
[TBL] [Abstract][Full Text] [Related]
4. Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Durante W; Johnson FK; Johnson RA
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):906-11. PubMed ID: 17645639
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
Tousoulis D; Böger RH; Antoniades C; Siasos G; Stefanadi E; Stefanadis C
Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):274-83. PubMed ID: 17457351
[TBL] [Abstract][Full Text] [Related]
6. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
7. Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders.
Gielis JF; Lin JY; Wingler K; Van Schil PE; Schmidt HH; Moens AL
Free Radic Biol Med; 2011 Apr; 50(7):765-76. PubMed ID: 21172428
[TBL] [Abstract][Full Text] [Related]
8. The pharmacodynamics of L-arginine.
Böger RH
Altern Ther Health Med; 2014; 20(3):48-54. PubMed ID: 24755570
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial cells synthesize nitric oxide from L-arginine.
Palmer RM; Ashton DS; Moncada S
Nature; 1988 Jun; 333(6174):664-6. PubMed ID: 3131684
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases.
Goumas G; Tentolouris C; Tousoulis D; Stefanadis C; Toutouzas P
Atherosclerosis; 2001 Feb; 154(2):255-67. PubMed ID: 11166757
[TBL] [Abstract][Full Text] [Related]
11. Exogenous hyaluronidase induces release of nitric oxide from the coronary endothelium.
Evora PR; Pearson PJ; Chua YL; Discigil B; Schaff HV
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):707-11. PubMed ID: 11003752
[TBL] [Abstract][Full Text] [Related]
12. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
[TBL] [Abstract][Full Text] [Related]
13. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
Böger RH
Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
[TBL] [Abstract][Full Text] [Related]
14. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
Pernow J; Jung C
Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041
[TBL] [Abstract][Full Text] [Related]
15. [The L-arginine-nitric oxide system: physiology, physiopathology and clinical relevance].
Garini G; Savazzi G; Borghetti A
Recenti Prog Med; 1997 Feb; 88(2):90-9. PubMed ID: 9148375
[TBL] [Abstract][Full Text] [Related]
16. [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
Bode-Böger SM
Dtsch Med Wochenschr; 2005 Mar; 130(11):593-8. PubMed ID: 15761791
[TBL] [Abstract][Full Text] [Related]
17. Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection?
Brunini TM; Mendes-Ribeiro AC; Ellory JC; Mann GE
Cardiovasc Res; 2007 Jan; 73(2):359-67. PubMed ID: 17078937
[TBL] [Abstract][Full Text] [Related]
18. The clinical pharmacology of L-arginine.
Böger RH; Bode-Böger SM
Annu Rev Pharmacol Toxicol; 2001; 41():79-99. PubMed ID: 11264451
[TBL] [Abstract][Full Text] [Related]
19. Nitrergic system and plasmatic methylarginines: Evidence of their role in the perinatal programming of cardiovascular diseases.
Bassareo PP; Mussap M; Bassareo V; Flore G; Mercuro G
Clin Chim Acta; 2015 Dec; 451(Pt A):21-7. PubMed ID: 26004093
[TBL] [Abstract][Full Text] [Related]
20. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
Miller AL
Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
